SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-007194
Filing Date
2021-02-05
Accepted
2021-02-05 17:28:27
Documents
7
Period of Report
2021-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea134769-8k_inmedpharma.htm 8-K 46192
2 FORM OF COMMON SHARE PURCHASE WARRANT ea134769ex4-1_inmed.htm EX-4.1 100657
3 PLACEMENT AGENCY AGREEMENT, DATED FEBRUARY 5, 2021 ea134769ex10-1_inmed.htm EX-10.1 66746
4 FORM OF SECURITIES PURCHASE AGREEMENT ea134769ex10-2_inmed.htm EX-10.2 261891
5 FORM OF REGISTRATION RIGHTS AGREEMENT ea134769ex10-3_inmed.htm EX-10.3 138418
6 PRESS RELEASE, DATED FEBRUARY 5, 2021 ea134769ex99-1_inmed.htm EX-99.1 14147
7 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
  Complete submission text file 0001213900-21-007194.txt   652477
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21597458
SIC: 2834 Pharmaceutical Preparations